- AU$845.92m
- AU$713.83m
- AU$203.89m
Annual balance sheet for NANOSONICS, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
R2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | 12 M | 12 M | 12 M | 12 M |
| Source: | Interim Report | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 94.5 | 112 | 130 | 162 | 155 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 28.2 | 39.1 | 41.3 | 38.8 | 47.4 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 151 | 182 | 198 | 225 | 241 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 22.6 | 22.5 | 20.7 | 24.4 | 40 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 187 | 220 | 237 | 272 | 302 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 28.6 | 33 | 32.2 | 39.8 | 43.3 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 48.5 | 56.1 | 55.1 | 62.6 | 84.7 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 139 | 164 | 182 | 210 | 218 |
| Total Liabilities & Shareholders' Equity | 187 | 220 | 237 | 272 | 302 |
| Total Common Shares Outstanding |